A Systematic Review of the Emerging Treatment for Hepatorenal Syndrome With a Principal Focus on Terlipressin: A Recent FDA-Approved Drug.

Thangaraj, Santhosh Raja; Srinivasan, Mirra; Arzoun, Hadia; Thomas, Siji S

Thangaraj, Santhosh Raja; Srinivasan, Mirra; Arzoun, Hadia; Thomas, Siji S.

Afiliación

Thangaraj SR; Internal Medicine, Rajah Muthiah Medical College and Hospital, Chidambaram, IND.
Srinivasan M; Internal Medicine, St. Bernards Medical Center, Jonesboro, USA.
Arzoun H; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Thomas SS; Internal Medicine, St. Bernards Medical Center, Jonesboro, USA.

Cureus ; 15(7): e42367, 2023 Jul.

Article en En | MEDLINE | ID: mdl-37621788

Palabras clave

albumin; cirrhosis; hepatorenal syndrome; midodrine; norepinephrine; octreotide; terlipressin

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google